Lista de obras -

Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations.

artículo científico publicado en 2015

Early HCC treatment: a future strategy against interferon/miR-484 axis to revert precancerous lesions?

artículo científico publicado en 2016

Epigenetic modulation of immunity: towards new therapeutic avenues in hepatocellular carcinoma?

artículo científico publicado en 2019

Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells

artículo científico publicado en 2005

Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography

artículo científico publicado en 2019

Hepatocellular carcinoma diagnosis: Circulating microRNAs emerge as robust biomarkers.

artículo científico publicado en 2016

Lymphoma and myeloma cell resistance to cytotoxic agents and ionizing radiations is not affected by exposure to anti-IL-6 antibody

artículo científico publicado en 2009

Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response

artículo científico publicado en 2010

MicroRNA-feedback loop as a key modulator of liver tumorigenesis and inflammation.

artículo científico publicado en 2013

Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.

artículo científico publicado en 2007

Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice

artículo científico publicado en 2012

T-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism in mice

artículo científico publicado en 2014

The concomitant loss of APC and HNF4α in adult hepatocytes does not contribute to hepatocarcinogenesis driven by β-catenin activation

artículo científico publicado en 2019

Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast

scientific article published on 10 July 2003

[Interleukin-6 and epithelial tumours: new convincing arguments in favour of the use of IL-6 targeted therapies].

artículo científico publicado en 2008

[Metabolic imaging assessing choline addiction in liver primary cancers predicts their oncogenotype and opens a new therapeutic avenue]

artículo científico publicado en 2020

microRNA: new diagnostic and therapeutic tools in liver disease?

artículo científico publicado en 2013

β-catenin-activated hepatocellular carcinomas are addicted to fatty acids

artículo científico publicado en 2018

Lista de obras de

Antitumour activity of an inhibitor of miR-34a in liver cancer with β-catenin-mutations.

Early HCC treatment: a future strategy against interferon/miR-484 axis to revert precancerous lesions?

Epigenetic modulation of immunity: towards new therapeutic avenues in hepatocellular carcinoma?

Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells

Hepatocellular Carcinomas With Mutational Activation of Beta-Catenin Require Choline and Can Be Detected by Positron Emission Tomography

Hepatocellular carcinoma diagnosis: Circulating microRNAs emerge as robust biomarkers.

Lymphoma and myeloma cell resistance to cytotoxic agents and ionizing radiations is not affected by exposure to anti-IL-6 antibody

Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response

MicroRNA-feedback loop as a key modulator of liver tumorigenesis and inflammation.

Oestrogen receptors pathways to oestrogen responsive elements: the transactivation function-1 acts as the keystone of oestrogen receptor (ER)beta-mediated transcriptional repression of ERalpha.

Oncogenic β-catenin triggers an inflammatory response that determines the aggressiveness of hepatocellular carcinoma in mice

T-cell factor 4 and β-catenin chromatin occupancies pattern zonal liver metabolism in mice

The concomitant loss of APC and HNF4α in adult hepatocytes does not contribute to hepatocarcinogenesis driven by β-catenin activation

Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast

[Interleukin-6 and epithelial tumours: new convincing arguments in favour of the use of IL-6 targeted therapies].

[Metabolic imaging assessing choline addiction in liver primary cancers predicts their oncogenotype and opens a new therapeutic avenue]

microRNA: new diagnostic and therapeutic tools in liver disease?

β-catenin-activated hepatocellular carcinomas are addicted to fatty acids